Healthcare -
Biotechnology - NASDAQ - US
$ 39.21
-0.835 %
$ 3.85 B
Market Cap
-14.85
P/E
SRPT - OPERATING INCOME
Operating Income SRPT - Sarepta Therapeutics, Inc.
218 M
LAST VALUE
55.14%
2 YEAR CAGR
19.31%
5 YEAR CAGR
13.76%
10 YEAR CAGR